Alector, Inc. Long-Term Debt
Alector, Inc. (ALEC) had Long-Term Debt of $0 as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2026-08-06
- 2026-06-30: Long-term Debt, Excluding Current Maturities $0.00.
- 2026-03-31: Long-term Debt, Excluding Current Maturities $8.29M.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $9.32M.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $9.61M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 |
| 2026-03-31 | $8.29M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $9.32M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $9.61M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $9.54M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $9.46M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $9.39M 10-K · filed 2026-02-25 |
| 2023-12-31 | $0.00 10-K · filed 2025-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |